Viewing Study NCT04260932


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-01-18 @ 3:07 PM
Study NCT ID: NCT04260932
Status: COMPLETED
Last Update Posted: 2022-03-08
First Post: 2020-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients
Sponsor: Hebei Yanda Ludaopei Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module